NGM Biopharmaceuticals, Inc.
LAIR-1-BINDING AGENTS AND METHODS OF USE THEREOF
Last updated:
Abstract:
The present disclosure provides binding agents, such as antibodies, that specifically bind LAIR-1, including human LAIR-1, as well as compositions comprising the binding agents, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising the binding agents.
Status:
Application
Type:
Utility
Filling date:
21 Jun 2021
Issue date:
10 Feb 2022